Estonia - estoniană - Ravimiamet

actavis group ptc ehf. - doksorubitsiin - süstelahuse pulber - 10mg 1tk

Estonia - estoniană - Ravimiamet

actavis group ptc ehf. - doksorubitsiin - süstelahuse pulber - 50mg 1tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukeemia, müeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Estonia - estoniană - Ravimiamet

accord healthcare b.v. - fludarabiin - süste-/infusioonilahuse kontsentraat - 25mg 1ml 2ml 1tk; 25mg 1ml 2ml 10tk

Estonia - estoniană - Ravimiamet

sandoz pharmaceuticals d.d. - fludarabiin - süste-/infusioonilahuse kontsentraat - 25mg 1ml 2ml 1tk; 25mg 1ml 2ml 5tk; 25mg 1ml 2ml 10tk

Estonia - estoniană - Ravimiamet

fresenius kabi oncology plc - fludarabiin - süste-/infusioonilahuse pulber - 50mg 50mg 1tk

Estonia - estoniană - Ravimiamet

actavis group ptc ehf. - fludarabiin - süste-/infusioonilahuse pulber - 25mg 1ml 2ml 5tk

Estonia - estoniană - Ravimiamet

actavis group ptc ehf. - fludarabiin - süste-/infusioonilahuse kontsentraat - 25mg 1ml 2ml 5tk

Estonia - estoniană - Ravimiamet

krka d.d. novo mesto - deksametasoon - süstelahus - 4mg 1ml 1ml 25tk

Uniunea Europeană - estoniană - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib dietüülfumaraat - leukeemia, müeloidne, äge - antineoplastilised ained - xospata on näidustatud monotherapy raviks täiskasvanud patsientidel, kes on taastekkinud või tulekindlad ägeda müeloidse leukeemia (aml), mille flt3 mutatsioon.